漳州片仔癀药业股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告

Core Viewpoint - The announcement details a significant equity change involving the major shareholder, Zhangzhou Jiulongjiang Group Co., Ltd., which plans to increase its stake in the company without altering the control structure [1][5]. Group 1: Shareholder Information - The major shareholder, Jiulongjiang Group, has committed to providing accurate and complete information regarding its equity changes [1]. - Jiulongjiang Group has no associated parties in this equity change [3]. Group 2: Equity Change Details - Jiulongjiang Group plans to increase its shareholding by investing between RMB 300 million and RMB 500 million from February 1, 2026, to July 31, 2026, without a set price range [1]. - The funding for this increase will come from Jiulongjiang Group's own resources and a special loan of up to RMB 450 million from Industrial and Commercial Bank of China, with a loan term of three years [2]. Group 3: Compliance and Future Commitments - The equity change complies with relevant regulations and will not trigger a mandatory bid or affect the company's governance structure [5]. - Jiulongjiang Group has committed not to reduce its shareholding for 12 months following the completion of the increase plan [5].